Gaweco AS et al. |
Distinct intragraft cytokine gene expression patterns during acute hepatic rejection under cyclosporine versus FK 506 primary immunosuppression. |
1994 |
Transplant. Proc. |
pmid:7527948
|
Lauzurica R et al. |
Subclinical inflammation in renal transplant recipients: impact of cyclosporine microemulsion versus tacrolimus. |
2007 |
Transplant. Proc. |
pmid:17889127
|
Ramos-Cebrián M et al. |
Conversion from tacrolimus to cyclosporine could improve control of posttransplant diabetes mellitus after renal transplantation. |
2007 |
Transplant. Proc. |
pmid:17889154
|
Watanabe K et al. |
Fate of long-surviving allografts in tolerant recipients induced by fractionated lymphoid irradiation, donor bone marrow cell infusion, and FK 506 after retransplantation in dogs. |
1993 |
Transplant. Proc. |
pmid:7679813
|
Burke GW et al. |
The use of FK506 in simultaneous pancreas/kidney transplantation: rescue, induction, and maintenance immunosuppression. |
1995 |
Transplant. Proc. |
pmid:8539874
|
Valdivia LA et al. |
Hamster-to-rat liver xenografts protect extrahepatic organs from rejection. |
1993 |
Transplant. Proc. |
pmid:7679816
|
Yasunami Y et al. |
Acceptance of donor-specific islet allografts in rat by intraportal preimmunization with islets and FK 506. |
1994 |
Transplant. Proc. |
pmid:7513467
|
Ryu S and Yasunami Y |
Prevention of immune rejection in rat islet allografts by continuous SC administration of FK 506 using a mini-osmotic pump. |
1991 |
Transplant. Proc. |
pmid:1703710
|
Thomson AW |
Interspecies comparison of the immunosuppressive efficacy and safety of FK 506. |
1990 |
Transplant. Proc. |
pmid:1689883
|
Pérez-Flores I et al. |
Intracellular ATP levels in CD4+ lymphocytes are a risk marker of rejection and infection in renal graft recipients. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715845
|
GarcÃa Meseguer C et al. |
Anti-HLA antibodies posttransplantation in children: do we know what it means? |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715846
|
Kedzierska K et al. |
Oxidative stress indices in rats under immunosuppression. |
2011 |
Transplant. Proc. |
pmid:22172876
|
Urbizu JM et al. |
Immunosuppression using tacrolimus/mycophenolate versus neoral/mycophenolate following kidney transplantation: a single-center experience. |
2002 |
Transplant. Proc. |
pmid:11959197
|
Pascual J and Ortuño J |
Simple tacrolimus-based immunosuppressive regimens following renal transplantation: a large multicenter comparison between double and triple therapy. |
2002 |
Transplant. Proc. |
pmid:11959198
|
Lian Y et al. |
Suppression of Delayed Xenograft Rejection by Resveratrol in a Hamster-to-Rat Cardiac Transplantation Model. |
|
Transplant. Proc. |
pmid:28736027
|
Shapiro R et al. |
Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression. |
1998 |
Transplant. Proc. |
pmid:9636557
|
Grewal HP et al. |
Corticosteroid cessation 1 week following renal transplantation using tacrolimus/mycophenolate mofetil based immunosuppression. |
1998 |
Transplant. Proc. |
pmid:9636558
|
Ochiai M et al. |
Islet toxicity of FK506 measured in canine autografts. |
1998 |
Transplant. Proc. |
pmid:9532224
|
Vathsala A et al. |
Inhibition of apoptosis in anti-CD3-treated peripheral blood lymphocytes by immunosuppressive drugs. |
2000 |
Transplant. Proc. |
pmid:11120034
|
Ueno T et al. |
Renal dysfunction following adult intestinal transplant under tacrolimus-based immunosuppression. |
2006 Jul-Aug |
Transplant. Proc. |
pmid:16908274
|
Shibata T et al. |
Does FK 506 accelerate the development of coronary artery disease in the transplanted heart as well as the native heart? |
1993 |
Transplant. Proc. |
pmid:7680147
|
Wu YM et al. |
Interaction between FK 506 and cyclosporine in dogs. |
1991 |
Transplant. Proc. |
pmid:1721281
|
Bora F et al. |
Drug interaction between tacrolimus and ertapenem in renal transplantation recipients. |
2012 |
Transplant. Proc. |
pmid:23195020
|
Horimoto H et al. |
Hepatocyte xenotransplantation for Nagase's analbuminemic rats: the effect of FK506. |
1996 |
Transplant. Proc. |
pmid:8623421
|
Crespo-Leiro MG |
Calcineurin inhibitors in heart transplantation. |
2005 |
Transplant. Proc. |
pmid:16386614
|
Tan HP et al. |
Steroid-free tacrolimus monotherapy after pretransplantation thymoglobulin or Campath and laparoscopy in living donor renal transplantation. |
2005 |
Transplant. Proc. |
pmid:16387087
|
McAlister VC et al. |
Cost of liver transplantation using tacrolimus. |
1998 |
Transplant. Proc. |
pmid:9636611
|
Lipson DA et al. |
Conversion to tacrolimus (FK506) from cyclosporine after orthotopic lung transplantation. |
1998 |
Transplant. Proc. |
pmid:9636612
|
Ohtsuka S et al. |
Effect of splenectomy on hamster-to-rat pancreas xenotransplantation. |
1994 |
Transplant. Proc. |
pmid:7518109
|
Lentine KL et al. |
Variation in Comedication Use According to Kidney Transplant Immunosuppressive Regimens: Application of Integrated Registry and Pharmacy Claims Data. |
|
Transplant. Proc. |
pmid:26915843
|
Yasutomi M et al. |
Mechanism of antibody production in hamster-to-rat concordant xenotransplantation: establishment of a simple model using intravenous injection of concordant splenocytes. |
1994 |
Transplant. Proc. |
pmid:7518110
|
Porayko MK et al. |
Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: preliminary results from US Multicenter trial. U.S. Multicenter Liver Study Group. |
1995 |
Transplant. Proc. |
pmid:7533358
|
Mueller AR et al. |
The superior immunosuppressant according to diagnosis: FK 506 or cyclosporine A. |
1995 |
Transplant. Proc. |
pmid:7533359
|
Wang SC et al. |
FK 506, rapamycin, and cyclosporine: effects on IL-4 and IL-10 mRNA levels in a T-helper 2 cell line. |
1991 |
Transplant. Proc. |
pmid:1721312
|
Kita J et al. |
Effects of tacrolimus on small and large bowel anastomoses in the rat. |
1999 |
Transplant. Proc. |
pmid:10578292
|
Woo J et al. |
Kinetics of early T-cell repopulation in the mouse following syngeneic bone marrow transplantation: FK 506 causes a maturational defect of CD4+ CD8- T cells. |
1991 |
Transplant. Proc. |
pmid:1721313
|
Kato T et al. |
Steroid-free induction and preemptive antiviral therapy for liver transplant recipients with hepatitis C: a preliminary report from a prospective randomized study. |
2005 |
Transplant. Proc. |
pmid:15848674
|
Iga C et al. |
Prolonged survival of small intestinal allograft in the rat with cyclosporine A, FK 506, and 15-deoxyspergualin. |
1990 |
Transplant. Proc. |
pmid:1697118
|
Ebbs A et al. |
Tacrolimus treats ongoing allograft rejection by inhibiting interleukin-10 mediated functional cytotoxic cell infiltration. |
2002 |
Transplant. Proc. |
pmid:12176404
|
Gagliano N et al. |
A therapeutic dose of FK506 does not affect collagen turnover pathways in healthy human gingival fibroblasts. |
2008 |
Transplant. Proc. |
pmid:18589121
|
Mortensen DM et al. |
Calcineurin activity in tacrolimus-treated renal transplant patients early after and 5 years after transplantation. |
2006 |
Transplant. Proc. |
pmid:17098028
|
Bäckman L et al. |
Steroid-free immunosuppression in kidney transplant recipients and prograf monotherapy: an interim analysis of a prospective multicenter trial. |
2006 |
Transplant. Proc. |
pmid:17098029
|
Masri MA |
Comparative study of toxicity and efficacy of cyclosporine, cyclosporine G (OG37), FK 506, and rapamycin in BALB/c mice with fitted skin grafts. |
1995 |
Transplant. Proc. |
pmid:7533412
|
Loucaidou M et al. |
Late steroid withdrawal for renal transplant recipients on tacrolimus and MMF is safe. |
2005 |
Transplant. Proc. |
pmid:15919469
|
Nakazato P et al. |
Early experience with FK 506 induction immunosuppression--suggestion for using oral FK 506. |
1991 |
Transplant. Proc. |
pmid:1721345
|
Malyszko J et al. |
A possible role of hepcidin in the pathogenesis of anemia among kidney allograft recipients. |
2009 |
Transplant. Proc. |
pmid:19857675
|
Takahashi K et al. |
Successful results after 5 years of tacrolimus therapy in ABO-incompatible kidney transplantation in Japan. |
2005 |
Transplant. Proc. |
pmid:15919471
|
Foroncewicz B et al. |
Safety and efficacy of steroid-free immunosuppression with tacrolimus and daclizumab in liver transplant recipients: 6-year follow-up in a single center. |
2009 |
Transplant. Proc. |
pmid:19857686
|
Lin YH et al. |
The 4-week serum creatinine level predicts long-term renal dysfunction after adult living donor liver transplantation. |
2012 |
Transplant. Proc. |
pmid:22483492
|
EscartÃn A et al. |
Analysis of pig-MAP after small bowel transplantation in pigs. |
1998 |
Transplant. Proc. |
pmid:9865377
|
Reis A et al. |
Mycophenolate mofetil and FK506: two novel immunosuppressants in murine corneal transplantation. |
1998 |
Transplant. Proc. |
pmid:9865380
|
Zhu Y et al. |
Prolongation of canine renal allograft survival by combining tacrolimus with antimetabolic agents. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123011
|
Naraghi RM et al. |
Long-term follow-up of tacrolimus rescue therapy for renal allograft rejection. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123013
|
Platz KP et al. |
Immunosuppressive power and limitations of FK 506 for prevention and treatment of graft-vs-host disease after small bowel transplantation. |
1996 |
Transplant. Proc. |
pmid:8907933
|
Velio P et al. |
Rejection and survival after total orthotopic liver-small bowel allotransplantation in pigs immunosuppressed with FK 506. |
1996 |
Transplant. Proc. |
pmid:8907936
|
Imanishi M et al. |
Induction of tolerance by intrathymic injection of donor bone marrow cells in the rat: simultaneous heart and skin allograft model. |
1994 |
Transplant. Proc. |
pmid:7520615
|
Matsuura T et al. |
Organ-specific tolerance induced by intrathymic injection of donor bone marrow cells and FK 506 or antilymphocyte serum in rat heart transplantation. |
1994 |
Transplant. Proc. |
pmid:7520616
|
Ueda D et al. |
Influence of FK 506 on renal blood flow. |
1991 |
Transplant. Proc. |
pmid:1721377
|
Pisitkun T et al. |
The roles of C4 and AUC0-4 in monitoring of tacrolimus in stable kidney transplant patients. |
2002 |
Transplant. Proc. |
pmid:12493410
|
Thomson AW et al. |
The influence of FK 506 on the thymus: implications of drug-induced injury to thymic epithelial cells. |
1991 |
Transplant. Proc. |
pmid:1703361
|
Guleria S et al. |
Generic tacrolimus (Pan Graf) in renal transplantation: an experience of 155 recipients in India. |
2008 |
Transplant. Proc. |
pmid:18790202
|
Tanabe K et al. |
Improved outcome of minor-mismatched living renal allografts under tacrolimus immunosuppression. |
2002 |
Transplant. Proc. |
pmid:12176528
|
Chen WY et al. |
Betel Nut Chewing Is Associated With Reduced Tacrolimus Concentration in Taiwanese Liver Transplant Recipients. |
2017 |
Transplant. Proc. |
pmid:28219593
|
Rastellini C et al. |
Prolonged survival of islet allografts following combined therapy with tacrolimus and leflunomide. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083278
|
Kim JD et al. |
Single-Center Experience of ABO-Incompatible Living-Donor Liver Transplantation With a New Simplified Intravenous Immunoglobulin Protocol: A Propensity Score-Matching Analysis. |
2016 |
Transplant. Proc. |
pmid:27320573
|
Kato H et al. |
Long-Term Influence of CYP3A5 Gene Polymorphism on Pharmacokinetics of Tacrolimus and Patient Outcome After Living Donor Liver Transplantation. |
2016 |
Transplant. Proc. |
pmid:27320564
|
Millis JM et al. |
Tacrolimus treatment of steroid-resistant rejection provides economic advantages compared with OKT3 therapy. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123421
|
Platz KP et al. |
Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients. |
1996 |
Transplant. Proc. |
pmid:8962235
|
Shinozuka H et al. |
Effect of FK 506 on experimental liver carcinogenesis. |
1991 |
Transplant. Proc. |
pmid:1721407
|
Cai X et al. |
Low-dose of FK 506 and associated blood levels in allotransplantation of rat liver, heart, and skin. |
1992 |
Transplant. Proc. |
pmid:1379759
|
Pelekanou V et al. |
FK 506 and rapamycin do not affect platelet aggregation or mitochondrial function. |
1991 |
Transplant. Proc. |
pmid:1721408
|
Taki J et al. |
DNA analysis of peripheral blood mononuclear cells for early detection of hepatic graft rejection. |
1992 |
Transplant. Proc. |
pmid:1379760
|
Langrehr JM et al. |
Quadruple versus dual tacrolimus-based induction after liver transplantation: a prospective, randomized trial. |
2001 |
Transplant. Proc. |
pmid:11377549
|
Uber PA et al. |
Steroid weaning in heart transplantation is associated with decreased B-type natriuretic peptide: surrogate evidence for cardiac adaptation. |
2002 |
Transplant. Proc. |
pmid:12176598
|
Nagashima N et al. |
Immunocompetence assay for net effect of combined immunosuppression. |
2001 |
Transplant. Proc. |
pmid:11377556
|
Baran DA et al. |
Tacrolimus and cardiac transplantation: a comparison of monotherapy and steroid-dependent patients. |
2002 |
Transplant. Proc. |
pmid:12176599
|
Calconi G and Vianello A |
One-year follow-up of a large European trial comparing dual versus triple tacrolimus-based immunosuppressive regimens following renal transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267173
|
Lang M et al. |
Combined liver-kidney transplantation: long-term follow-up in 18 patients. |
1998 |
Transplant. Proc. |
pmid:9723313
|
Ersoy A et al. |
Diabetic ketoacidosis following development of de novo diabetes in renal transplant recipient associated with tacrolimus. |
2004 |
Transplant. Proc. |
pmid:15251345
|
Renner FC et al. |
The risk of polyomavirus-associated graft nephropathy is increased by a combined suppression of CD8 and CD4 cell-dependent immune effects. |
2013 |
Transplant. Proc. |
pmid:23726630
|
Sato K et al. |
Comparative study of FK 506, cyclosporine, and triple regimen immunosuppression with FK 506, cyclosporine, and mizoribine. |
1991 |
Transplant. Proc. |
pmid:1721440
|
Eberlin M et al. |
Increased medication compliance of liver transplant patients switched from a twice-daily to a once-daily tacrolimus-based immunosuppressive regimen. |
2013 Jul-Aug |
Transplant. Proc. |
pmid:23726723
|
Odocha O et al. |
Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression. |
1993 |
Transplant. Proc. |
pmid:7689268
|
Ochiai T et al. |
Effects of FK-506 on xenotransplantation of the heart and skin in a mouse-rat combination. |
1987 |
Transplant. Proc. |
pmid:2445083
|
Markus BH et al. |
Daclizumab induction therapy in combination with tacrolimus. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267354
|
Laftavi MR et al. |
The role of antibiotic prophylaxis in the new era of immunosuppression. |
2011 |
Transplant. Proc. |
pmid:21440753
|
Langrehr JM et al. |
IL-2 receptor antibody induction increases the risk for chronic rejection after liver transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267360
|
González MG et al. |
Comparison of post-liver transplantation electrocardiographic alterations between cyclosporine- and tacrolimus-treated patients. |
1999 |
Transplant. Proc. |
pmid:10500652
|
González-Pinto I et al. |
Usefulness of the switch to tacrolimus in liver transplantation. |
1999 |
Transplant. Proc. |
pmid:10500653
|
Tsujimura K et al. |
Effect of Influenza Vaccine in Patients With Kidney Transplant. |
2018 |
Transplant. Proc. |
pmid:30316375
|
Shullo MA et al. |
Elevated tacrolimus levels associated with intravenous azithromycin and ceftriaxone: a case report. |
2010 |
Transplant. Proc. |
pmid:20620540
|
Rao V et al. |
A non-induction renal sparing approach after liver transplantation: high dose mycophenolate mofetil with delayed, low-dose tacrolimus. |
2013 Jan-Feb |
Transplant. Proc. |
pmid:23267806
|
Starzl TE et al. |
Notes on FK 506. |
1991 |
Transplant. Proc. |
pmid:1714647
|
Haba T et al. |
Pathological and immunohistochemical examination in the rat treated with FK 506. |
1991 |
Transplant. Proc. |
pmid:1714649
|
Kahu J et al. |
Impact of mycophenolate mofetil intolerance on early results of kidney transplantation. |
2005 |
Transplant. Proc. |
pmid:16298571
|
Suarez Benjumea A et al. |
Hepatitis C Virus in Kidney Transplant Recipients: A Problem on the Path to Eradication. |
2016 |
Transplant. Proc. |
pmid:27932111
|
Xie L et al. |
Pretransplantation Risk Factors Associated With New-onset Diabetes After Living-donor Kidney Transplantation. |
2016 |
Transplant. Proc. |
pmid:27931572
|
Eghtesad B et al. |
Use of tacrolimus as the primary immunosuppression after renal transplant in Native Americans and Hispanics. |
1998 |
Transplant. Proc. |
pmid:9636500
|
Rathi M et al. |
Conversion from tacrolimus to cyclosporine in patients with new-onset diabetes after renal transplant: an open-label randomized prospective pilot study. |
2015 |
Transplant. Proc. |
pmid:26036543
|
Pichlmayr R et al. |
Three-year follow-up of the European Multicenter Tacrolimus (FK506) Liver Study. |
1997 |
Transplant. Proc. |
pmid:9270825
|